All In Biotech

Drug Trial Radar · NCT00003057

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Jun 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

500

Planned (sponsor's estimate)

Start

Mar 26, 1997

Primary completion

May 2000

Sponsor

Lead sponsor
Eastern Cooperative Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); SWOG Cancer Research Network; Cancer and Leukemia Group B
First posted
Jul 19, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Supportive care
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.

Conditions

  • Colorectal Cancer
  • Diarrhea

Interventions

  • loperamide hydrochlorideDrug

  • octreotide acetateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • University of California San Diego Cancer Center

    La Jolla, California

  • UCSF Cancer Center and Cancer Research Institute

    San Francisco, California

  • CCOP - Christiana Care Health Services

    Wilmington, Delaware

  • Walter Reed Army Medical Center

    Washington D.C., District of Columbia

  • CCOP - Mount Sinai Medical Center

    Miami Beach, Florida

  • University of Illinois at Chicago Health Sciences Center

    Chicago, Illinois

  • University of Chicago Cancer Research Center

    Chicago, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland

    Baltimore, Maryland

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota

  • Ellis Fischel Cancer Center - Columbia

    Columbia, Missouri

  • Barnes-Jewish Hospital

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • CCOP - Southern Nevada Cancer Research Foundation

    Las Vegas, Nevada

  • Norris Cotton Cancer Center

    Lebanon, New Hampshire

  • CCOP - North Shore University Hospital

    Manhasset, New York

  • North Shore University Hospital

    Manhasset, New York

  • Memorial Sloan-Kettering Cancer Center

    New York, New York

  • New York Presbyterian Hospital - Cornell Campus

    New York, New York

  • Mount Sinai Medical Center, NY

    New York, New York

  • CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.

    Syracuse, New York

  • State University of New York - Upstate Medical University

    Syracuse, New York

  • Lineberger Comprehensive Cancer Center, UNC

    Chapel Hill, North Carolina

  • Duke Comprehensive Cancer Center

    Durham, North Carolina

  • CCOP - Southeast Cancer Control Consortium

    Winston-Salem, North Carolina

  • Comprehensive Cancer Center of Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina

  • Rhode Island Hospital

    Providence, Rhode Island

  • Medical University of South Carolina

    Charleston, South Carolina

  • University of Tennessee, Memphis Cancer Center

    Memphis, Tennessee

  • Vermont Cancer Center

    Burlington, Vermont

  • MBCCOP - Massey Cancer Center

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.